Your session is about to expire
← Back to Search
Communication Strategies for HPV Vaccination
N/A
Waitlist Available
Led By Noel T Brewer, PhD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two ways to improve HPV vaccination communication in primary care. Clinics will receive training from outside expert or internal vaccine champion.
Who is the study for?
This trial is for primary care clinics that serve children aged 9-12, specializing in pediatrics or family medicine. Clinics will be enrolled and their staff trained to communicate about HPV vaccination; however, children won't be directly involved.
What is being tested?
The study compares two training methods aimed at improving HPV vaccine discussions: one delivered by an external expert and the other by a 'vaccine champion' from within the healthcare system itself.
What are the potential side effects?
Since this trial focuses on communication training rather than medical interventions, there are no direct side effects related to medications or vaccines being studied.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from baseline to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
HPV vaccination (≥1 dose), 9-12 year olds
Secondary study objectives
HPV vaccination (2 doses), 9-12 year olds
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Traditional AATExperimental Treatment1 Intervention
Staff in clinics randomized to this arm will also receive Announcement Approach Training (AAT). The training will be organized and delivered by outside experts.
Group II: Champion AATExperimental Treatment1 Intervention
Staff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination. The training will be organized and delivered by vaccine champions from participating healthcare systems.
Find a Location
Who is running the clinical trial?
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
365 Previous Clinical Trials
92,680 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,957 Previous Clinical Trials
41,112,047 Total Patients Enrolled
University of Wisconsin, MadisonOTHER
1,237 Previous Clinical Trials
3,200,939 Total Patients Enrolled
Noel T Brewer, PhDPrincipal InvestigatorUniversity of North Carolina
8 Previous Clinical Trials
5,568 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not between 9 and 12 years old.My clinic does not offer primary care to children aged 9-12.I am between 9 and 12 years old.My clinic offers primary care to children aged 9-12.
Research Study Groups:
This trial has the following groups:- Group 1: Traditional AAT
- Group 2: Champion AAT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.